BRIEF published on 08/08/2025 at 17:50, 7 months 17 days ago POXEL Begins Judicial Reorganization Proceedings Metabolic Diseases Euronext Listing Judicial Recovery Steatohepatitis Observation Period
PRESS RELEASE published on 08/08/2025 at 17:45, 7 months 17 days ago Informations privilégiées / Autres communiqués POXEL annonce l'ouverture d'une procédure de redressement judiciaire avec reprise de cotation de l'action le 11 août 2025. La société biopharmaceutique explore ses options pour poursuivre ses activités Biopharmaceutique Cotation Redressement Judiciaire Procédure Poxel
BRIEF published on 07/29/2025 at 20:21, 7 months 27 days ago Poxel Initiates Reorganization Amid Financial Struggles Creditors Reorganization Insolvency Corporate Changes Poxel
BRIEF published on 07/29/2025 at 20:21, 7 months 27 days ago Poxel entame une réorganisation en raison de difficultés financières Créanciers Reorganisation Insolvabilité Poxel Changements D'entreprise
PRESS RELEASE published on 07/29/2025 at 20:16, 7 months 27 days ago Inside Information / Other news releases Poxel provides update on negotiations with creditors, announces reorganization proceedings & corporate governance change with trading suspension. Press release details Lyon Court filing for insolvency & governance impact Governance Creditors Reorganization Trading Suspension Poxel
PRESS RELEASE published on 07/29/2025 at 20:16, 7 months 27 days ago Informations privilégiées / Autres communiqués Poxel annonce dépôt requête redressement judiciaire, changement gouvernance, suspension cotation. Négociations créanciers et transition opérationnelle en cours Gouvernance Créanciers Transition Redressement Judiciaire Poxel
BRIEF published on 07/08/2025 at 18:51, 8 months 17 days ago Informations sur le capital et les droits de vote de Poxel Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 07/08/2025 at 18:51, 8 months 17 days ago Information on Poxel's capital and voting rights Share Capital Voting Rights Actions AMF Poxel
PRESS RELEASE published on 07/08/2025 at 18:46, 8 months 17 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel communique le nombre total d'actions et de droits de vote composant son capital social conformément à la réglementation AMF Capital Social Actions AMF Réglementé Poxel
BRIEF published on 06/19/2025 at 17:51, 9 months 6 days ago Key Scientific Presentations on Imeglimin at ADA 2025 Diabetes Therapeutic Potential Sumitomo Pharma Imeglimin Scientific Presentations
Published on 03/26/2026 at 04:55, 2 hours 35 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 6 hours 50 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 7 hours ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 12 hours 15 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 18 hours ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/26/2026 at 07:11, 18 minutes ago Berentzen-Gruppe Aktiengesellschaft publishes its 2025 Annual Report – Berentzen Group achieves significant consolidated profit
Published on 03/26/2026 at 07:07, 22 minutes ago Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
Published on 03/26/2026 at 07:05, 24 minutes ago Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Published on 03/26/2026 at 07:05, 25 minutes ago EDAG Group: Market uncertainty and delayed awarding of projects shape FY 2025 – Strategic measures accelerated to restore sustainable growth and competitiveness
Published on 03/26/2026 at 07:00, 29 minutes ago WashTec AG: New record revenue of €498.6m with further increase in EBIT margin to 9.8% - at con-stant exchange rates revenue exceeds €500m for the first time
Published on 03/25/2026 at 18:53, 12 hours 36 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 12 hours 58 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 12 hours 58 minutes ago Performance soutenue des Investissements et déploiement actif de la stratégie
